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REVIEW ARTICLE
Reconsidering Osteoconduction in the Era
of Additive Manufacturing
Franz E. Weber, PhD1,2,3
Bone regeneration procedures in clinics and bone tissue engineering stand on three pillars: osteoconduction,
osteoinduction, and stem cells. In the last two decades, the focus in this field has been on osteoinduction, which
is realized by the use of bone morphogenetic proteins and the application of mesenchymal stem cells to treat
bone defects. However, osteoconduction was reduced to a surface phenomenon because the supposedly ideal
pore size of osteoconductive scaffolds was identified in the 1990s as 0.3–0.5mm in diameter, forcing bone
formation to occur predominantly on the surface. Meanwhile, additive manufacturing has evolved as a new tool
to realize designed microarchitectures in bone substitutes, thereby enabling us to study osteoconduction as a
true three-dimensional phenomenon. Moreover, by additive manufacturing, wide-open porous scaffolds can be
produced in which bone formation occurs distant to the surface at a superior bony defect-bridging rate enabled
by highly osteoconductive pores 1.2mm in diameter. This review provides a historical overview and an updated
definition of osteoconduction and related terms. In addition, it shows how additive manufacturing can be
instrumental in studying and optimizing osteoconduction of bone substitutes, and provides novel optimized
features and boundaries of osteoconductive microarchitectures.
Keywords: osteoconduction, microarchitecture, bone substitute, additive manufacturing, 3D printing, ceramics,
osseointegration, osteoinduction
Impact Statement
This review updates the definition of osteoconduction and draws clear lines to discriminate between osteoconduction,
osseointegration, and osteoinduction. Moreover, additively manufactured libraries of scaffolds revealed that:
 osteoconduction is more a three-dimensional than a surface phenomenon;
 microarchitecture dictates defect bridging, which is the measure for osteoconduction;
 pore diameter or the diagonal of lattice microarchitectures of osteoconductive bone substitutes should be *1.2mm.
History of Osteoconduction
The recognition of osteoconduction as an importantdriving force during bone regeneration is strongly as-
sociated with the use of allogeneic or xenogeneic bone as a
bone substitute to fill a bony defect. In 1628, Meekeren
reported in his book ‘‘Observationes medicochirurgicae’’1
the use of a canine bone to treat a skull defect in a Russian
nobleman. Despite the successful treatment, the patient was
not satisfied with the outcome because in the view of the
church he was now dehumanized and therefore faced a
choice between excommunication, which was a death sen-
tence in those times, or removal of the xenogeneic material.2
Observations on osteogenesis and the importance of the
periosteum were first reported in 1742 by Duhamel (as re-
viewed in Chase and Herndon3). Research on bone substitute
materials, as we know it, started in the second half of the 18th
century. At that time, Ollier performed research on bone re-
generation, and introduced the terms autogeneic, allogeneic,
and xenogeneic bone grafts4 (Table 1). Profound knowledge
regarding the fate of bone grafts was generated by histological
studies by Barth published in 1893 and 1895.2,5 He also coined
the term: ‘‘schleichender Ersatz,’’ that is, creeping substitu-
tion, describing the gradual replacement of the bone transplant
by newly formed bone based on neovascularization from
the bony bed where the transplant was placed. The term
1Oral Biotechnology and Bioengineering, Center of Dental Medicine Department of Cranio-Maxillofacial and Oral Surgery, University
of Zurich, Zurich, Switzerland.
2Center for Applied Biotechnology and Molecular Medicine (CABMM), University of Zurich, Zurich, Switzerland.
3Zurich Center for Integrative Human Physiology (ZIHP), University of Zurich, Zurich, Switzerland.
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‘‘creeping substitution’’ was established in the English-
speaking world by Phemister in 1926.6 The work of Barth was
mainly based on histology, and was continued by Axhausen7
on rabbit and rat samples and substantiated by human samples.
In 1914, an overview of the concept of bone grafts in
surgery was read at the annual meeting of the Canadian
Medical Association by Turner.8 According to Turner, the
three main theories of regeneration of bone by autografts at
that time were (1) by G. Axhausen (1877–1960): ‘‘The bone
in the graft always dies, is absorbed and reformed from
periosteum, which alone remains living in transplants.’’; (2)
by W. McEwan (1848–1924): ‘‘The bone in a graft is re-
produced from the proliferation of osteoblasts, derived from
osteoblasts within the bone of the graft itself’’; and (3) by
J.B. Murphy (1857–1916): The ‘‘graft is not osteogenetic,
but simply osteoconductive. Provided it be in contact at one
or both extremities with other living bone, the graft acts
simply as a scaffolding for the growth of the capillaries with
their osteogenetic cells as they advance from the living
contact extremities into the graft.’’ Therefore, it was J.B.
Murphy before World War I who, most likely, coined the
term osteoconduction, and certainly realized that osteo-
conduction was an important driving force for bone regen-
eration induced by autografts.
Definition of Osteoconduction and Closely
Related Terms
Osteoconduction
Osteoconduction is defined as a three-dimensional (3D)
process of ingrowth of sprouting capillaries, perivascular
tissue, and osteoprogenitor cells from a bony bed into the
3D structure of a porous implant (adjusted from Cornell and
Lane9; Urist10) used as a guiding cue to bridge a defect with
bony tissue.
This implies that osteoconduction is a 3D phenomenon,
and that biological readouts for osteoconduction are the ve-
locity of bone ingrowth into 3D structures or the bony
bridging of a defect,11,12 a notable diagnostic feature of
nonunions. This underlines the directional aspect of osteo-
conduction as a guiding cue to avoid nonunions. As stated by
Urist,10 ‘‘Osteoconduction occurs within a framework of
nonbiologic materials such as glass, ceramics, and plastics, as
well as within nonviable biologic materials such as auto-
claved bone, deproteinized bone, demineralized-trypsinized
bone, and frozen or freeze-dried allogeneic bone.
In nonbiologic frameworks, osteoconduction may occur
without resorption of the underlying framework. In nonvi-
able biologic frameworks, osteoconduction may occur with
or without resorption of the implanted material. In a viable
bone autograft, osteoconduction is facilitated by osteoinductive
processes and is more rapid than osteoconduction by non-
biologic materials.’’ Because osteoconduction occurs inde-
pendently from osteoinductive factors originating from the
scaffold, it is the main driving force for bone regeneration for
nonviable and synthetic bone substitute scaffolds.
Osseointegration
Osseointegration is defined as establishment of a direct
contact between implant and bone achieved, and main-
tained, during functional loading (adjusted from Albrektsson
et al.13; Branemark et al.14).
Osseointegration appears as more of a two-dimensional
(2D) surface phenomenon, and describes the direct contact
between the surface of an implant and bone. Its biological
readout is percentage of bone-to-implant contact or the forces
needed to remove the implant from the bone. The rigid fix-
ation of an implant in orthopedic praxis can be determined
using radio-stereophotogrammetic techniques and, at least in
craniofacial implantology, resonance frequency analysis.15
Osseointegration is of great importance for dental implants,
which are primarily made from titanium. Moderately rough
surface topographies of dental titanium-based implants,
which can be achieved by surface etching and sandblasting,
appear to be optimal for osseointegration at the micro- and
nanolevel.16–18 This can reflect preferential binding of blood
components due to optimal combination of nanostructures
and hydrophilicity on the surface.18–20
Osteoinduction
Osteoinduction is defined as the induction of undifferenti-
ated mesenchymal stem cells that are not yet committed to the
osteogenic lineage to form osteoprogenitor cells and to pro-
duce bone at heterotopic sites (adjusted from Urist10; Barradas
et al.21; Friedenstein et al.22).
Osteoinduction, in contrast with osteoconduction and os-
seointegration, is not restricted to bony beds but acts also at
ectopic sites, such as in subcutaneous pouches in animal
models. Therefore, the biological readout for osteoinduction is
the extent of bone formation at an ectopic site. Levander
observed osteoinduction in 1934 when he injected crude al-
coholic extracts of bone into muscles.23,24 The search for the
bone inducing principle started with the groundbreaking ob-
servations by Urist in 1965,25 describing normal bone for-
mation in the form of ossicles, after implantation of
demineralized bone matrix in soft tissues of rabbits, rats, mice,
and guinea pigs. These observations finally led to the dis-
covery and cloning of bone morphogenetic proteins (BMPs),26
which have been used clinically in the form of human re-
combinant BMP-2 since the beginning of this century.27
BMPs and therefore osteoinduction play an essential role
in any bone formation activity. BMPs are secreted by os-
teoblasts and deposited in the bone matrix to coordinate
bone remodeling.28 Osteoinduction has also been seen with
hydroxyapatite-based scaffolds at ectopic sites without the
addition of BMPs.29 One can speculate that endogenous
BMPs in circulation bind to the hydroxyapatite disk and that
at a certain biological threshold of bound endogenous
BMPs, the formerly osteoconductive scaffold gradually ac-
quires osteoinductive features.30 In a more recent study with
tricalcium phosphate (TCP), different sintering temperatures
induced changes in microporosities correlated with os-
teoinductive potential in muscle pouches of dogs.31 Overall,
Table 1. Terminology for Bone Graft Operations
Noun Adjective Donor
Autograft Autogeneic Same individual
Isograft Isogeneic Identical twin or inbred strain
Allograft Allogeneic Same species, living
Alloimplant Allogeneic Same species, dead
Xenograft Xenogeneic Another species
According to Barth.2
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topography, concavities, composition, macropore size, per-
cent porosity, and microporosities can tune calcium-
phosphate-based scaffolds toward osteoinduction.32 For
concavities, it appears that 90 days after implantation, dif-
ferentiating osteoblast-like cells reside in the concavities, and
secrete and embed osteogenic molecular signals, such as os-
teogenic protein-1 (BMP-7), into these smart concavities.33
However, definitive evidence of the enrichment of circulating
BMPs on calcium phosphate-based scaffolds is still elusive.
Moreover, notably, these scaffolds were tested and found
useful in muscle pouches but failed in subcutaneous pouches.
Therefore, this osteoinductivity could depend on the proximity
to muscle-derived mesenchymal stem cells and mechanical
interactions between the rigid scaffold and the muscle fibers,
which could induce repair mechanisms in the muscle, includ-
ingmigration ofmuscle-derivedmesenchymal stemcells to the
implanted scaffold.34 However, in bone defects, these os-
teoinductive calcium-phosphate-derived scaffoldswere shown
to perform better than nonosteoinductive scaffolds with lower
microporosities31 and appear to be a promising material for
bone substitutes. However, thus far commercial enterprises
that based their products on this technology have failed in
the market. Whether the superior performance of these os-
teoinductive calcium-phosphate-derived scaffolds in bony
beds is due to binding of circulating autologous BMP to mi-
croporosities has neither been proven nor dismissed up to now.
Osteoconduction and Surface of the Implant
Osteoconduction, defined as directed bone ingrowth into
the voids of a porous scaffold to close a bony defect, is best
illustrated in Figure 1 for wide-open porous scaffolds con-
structed from titanium and TCP. For both titanium (Fig. 1a,
c) and TCP (Fig. 1b, d) materials, the bone formed between
the rods and barely on the surface of the rods when growing
through the empty space in a scaffold placed in a noncritical
cranial defect in rabbits. Thus, for osteoconduction to occur,
the rods of the scaffold serve as guiding cues to direct bone
growth and close the bony defect even without physical
contact between the newly formed bone and the material.
Therefore, osteoconduction can best be illustrated and
studied with wide-open porous scaffolds because bone growth
in channels of £0.4mm occurs on the channel walls,35 and the
influence of the material and its surface on bone ingrowth
might become more prominent. This notion is supported by
the slowdown of bone ingrowth in lattice structures with a rod
distance of 0.3mm compared with a rod distance of 0.8mm.
For a rod distance of 0.8mm, the defect was 90.83– 16.22%
bridged, compared with a rod distance of 0.3mm, where to
only 57.50– 24.57% bony bridging occurred.36
This suggests that bone ingrowth is significantly faster, and
thus osteoconduction is optimized in wide-open micro-
architectures comparedwith narrower counterparts,36 and that
the surface component overpowers osteoconduction in narrow
structures. The results from narrow microarchitectures might
be the reason for a definition of osteoconduction as provided in
a previous study15: ‘‘This term (osteoconduction) means that
bone grows on a surface.’’ Such a definition reduces osteo-
conduction to a 2D phenomenon, loses sight of the strong 3D
andguiding contribution associatedwith osteoconduction, and
might only apply to less osteoconductive scaffolds with nar-
row porous systems.35
Others have linked osteoconduction to osseointegration,
and defined it as ‘‘the recruitment and migration of osteo-
genic cells to the implant surface.’’37 In the author’s view,
this is also a misguided use of the term osteoconduction and
describes the early stages of osseointegration. From our
experience with wide-open porous structures, the woven
bone (purple in Figure 2), which forms first, is deposited
between and preferentially distant to the titanium rods. The
lamellar bone, which forms next and on top of the woven
bone (grayish in Fig. 2), is deposited in layers toward the
FIG. 1. Histological sec-
tions from the middle of the
defect from one exemplary
animal 4 weeks postopera-
tive. (a) Titanium implant,
(b) TCP implant. The yellow
line underneath indicates the
defect margins. (c) Higher
magnification from (a). (d)
Higher magnification from
(b). Scale bars in (a) and (c)
indicate 1mm, and apply to
(b) and (d) as well. Bone
appears as grayish purple to
blue. (a) and (b) are derived
from Chen et al.99 with per-
mission. TCP, tricalcium
phosphate.
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titanium scaffold. This indicates that the initial bone formed
in the scaffold barely touches the scaffold but uses it more
indirectly as 3D guiding cue to close the bony defect. Thus,
osteoconduction in wide-open porous structures refers to
woven bone growing through a scaffold. Only in the next
phase is the scaffold osseointegrated to some extent, pri-
marily by lamellar bone formed in layers on top of the
initially deposited woven bone.
In essence, for wide-open porous structures, bone growth
into the scaffold occurs predominantly between the rods and
barely on the surface of the rods. This could be the reason
why surface optimization of wide-open titanium lattice
structures, ranging from selective laser-melted surfaces to
sandblasted and sandblasted acid-etched titanium scaffolds,
had no significant influence on defect bridging.38 One could
speculate that the influence of the surface on osteoconduction
for wide-open scaffolds is reduced compared with narrow
structures. This notion is supported by results from tunnel
systems of different diameters in hydroxyapatite scaffolds,
where bone grew on the walls of the tunnels until a diameter
of 0.4mm. At diameters of 0.5 and 0.6mm, bone started to
grow in the middle of the tunnels35 without direct exposure to
the surface of the material. These numbers should also rep-
resent the lower limit for wide-open microarchitectures.
Osteoconduction and Microarchitecture
The macroarchitecture of a scaffold is defined as its
overall outer shape. Its inner microarchitecture comprises
pore size, shape, porosity, spatial distribution, channels,
and pore interconnection, and its nanoarchitecture includes
the inner and outer surfaces. Nanoarchitecture is deter-
mined by the production methodology or by the surface
modifications applied after the initial production proce-
dure.39–41 In the context of bone regeneration, the micro-
architecture of cancellous bone, with its large surface area, was
found to be superior to that of cortical bone because it has a
greater potential for forming new bone.42,43 Therefore, repro-
duction of cancellous bone-mimicking structures was at-
tempted during the development of synthetic bone substitutes;
for example, through a search for similar natural structures,
such as the exoskeleton of marine species.44 This is certainly a
major misconception in the search for the most osteoconduc-
tive microarchitecture because the microarchitecture of cortical
bone reflects the local mechanical needs,45 and thus, no evo-
lutionary pressure exists on osteoconduction in terms of
bone ingrowth into 3D structures.
For wide-open porous titanium-based structures, no sig-
nificant difference exists between the more ‘‘artificial’’ lattice
and the more ‘‘natural’’ porous structures.41 This suggests
that the search for osteoconductive microarchitectures should
not be limited to natural porous structures but can encompass
any microarchitecture generated in silica46 with computer-
aided design software.
Osteoinduction in a rat ectopic model through delivery of
BMP-2 through solid or porous hydroxyapatite particles il-
lustrated the necessity for porosity in bone formation.47 The
porosity of 3D biomaterial scaffolds and osteogenesis has
been reviewed extensively.48 More recent studies reported
on bone ingrowth and the presence of cells in micropores
well <0.1mm in diameter.49–51 However, the minimum re-
commended pore size for bone substitute scaffolds is
0.1mm,52 but was suggested to exceed 0.3mm in diame-
ter.48 An extended study with several TCP-based scaffolds
with macropores of 0.15mm in diameter showed no dif-
ference between diverse microporosities.53 Therefore, the
question of the influence of microporosities on osteo-
conduction has not yet been answered.
In textbooks and review articles, a pore diameter of 0.3–
0.5mm has long been regarded as the optimal size for
FIG. 2. High-magnification images of histological sections from the middle of the defect 8 weeks postoperative. Titanium
implant with a (a, d) native selective laser melted (SLM), (b, e) sandblasted SLM, and (c, f) sandblasted and acid-etched SLM
surface. The white square indicates the location of the related higher magnification picture in the lower panel. Black scale bars
(upper panel) indicate 500mm; white scale bars (lower panel) indicate 100mm. Original magnifications were 200 (a–c)- and
1000 (d–f)-fold. Titanium (black) is indicated by Ti. The grayish-stained bone tissue is lamellar bone (also new but formed
later) on the initial woven bone structures stained purple. Figure is reproduced with permission from de Wild et al.38
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osteoconduction, enabling efficient Haversian type47 and
trabecular32 bone formation. An optimal pore dimension of
0.2–0.5mm is also supported by several in vitro studies
(reviewed in Perez and Mestres54), although in vitro studies
poorly reflect the situation in a bony bed, which is a pre-
requisite for osteoconduction to occur. Two in vivo studies,
which set the optimal pore size between 0.3 and 0.4mm, used
an osteoinduction instead of an osteoconduction in vivo mod-
el.35,55 Since osteoinduction can overwrite osteoconduction,
these results should not be used to define the optimal pore
size for an osteoconductive microarchitecture.
There are reports that bone substitutes with pore sizes in
excess of 0.4mm are less conducive to new bone formation.55
In such a report, osteoconduction was tested in cortical win-
dows of proximal tibias in rabbits with hydroxyapatite-based
scaffolds, featuring parallel cylindrical pores of various sizes
from 0.05 to 0.5mm diameter without any interconnecting
fenestration between adjacent pores. Here, the most favorable
dimension was with channels 0.3mm in diameter. However,
the comparison was not based on defect bridging but on an
increase in compression strength after an 8-week period.56
In contrast to porous or open-porous microarchitectures,
single channels of defined diameters without interconnections
present a situation of limited nutrient supply and insufficient
waste removal, and might not be the ideal test system to define
the most osteoconductive microarchitecture. Therefore, in the
view of the author, the conclusion based on single channels,
specifically, that pore sizes in excess of 0.4mm are less
conductive is ill suited to define the upper limit of an osteo-
conductive pore size. Larger pores with wide-open intercon-
nections are certainly more favorable for nutrient supply and
waste removal within the scaffold, first through diffusion and
later on through vascularization. However, a guiding compo-
nent of the scaffold central for osteoconduction might yield a
natural limitation of the osteoconductive pore size irrespective
of its influence on the mechanics of the scaffold.
Additional conflicting results concerning diverse materi-
als and optimal pore size for osteoconduction are provided
in this paragraph. A long-term study was performed with
tantalum-based scaffolds with interconnected pores of 0.43
and 0.65mm. At 4 weeks, bone ingrowth into the scaffolds
was significantly better with larger pores. However, at 52
weeks, the scaffold with smaller pores showed better in-
growth.57 In another study, biphasic calcium phosphate ce-
ramic scaffolds were implanted into a distal femoral site in
rabbits to compare pores of 0.36mm with pores of 0.56mm,
and the larger pores were found to be more beneficial.58 In
contrast, when poly(propylene fumarate)-based scaffolds
with pores between 0.3 and 0.5mm and pores between 0.6
and 0.8mm were tested in a calvarial defect model in rab-
bits, no significant difference could be observed in inflam-
mation and bone formation.59
Porous titanium-based scaffolds fabricated by vacuum dif-
fusion bonding of titanium meshes with pores of 0.188, 0.313,
and 0.390mm in diameter have been tested for bone ingrowth.
In an in vitro test for cell ingrowth and cell proliferation, the
smallest (0.188mm) pores performed best. However, in vivo,
the most extended (0.390mm) pores outperformed the smaller
ones,60 illustrating that bigger pores are superior in vivo, and
that in vitro results on osteoconduction do not reflect the
in vivo outcome. It is undisputed that implant surfaces play
important roles in regulating protein adsorption and deter-
mining subsequent cell responses, including cell attachment,
proliferation, migration, and differentiation.61 However,
in vitro studies with cells have suggested osteoconductive
potential of surfaces, contradicting in vivo results.62,63 This is
reasonable because the prerequisite for osteoconduction in-
volves placement of the scaffold in a bony bed and additional
features, such as vascularization, which are presently lacking
in currently available in vitro systems.
In essence, the presently available in vitro systems are not
suited to study osteoconductive microarchitectures. More-
over, the majority of in vivo studies have been performed
with scaffolds containing randomly distributed pores and
undefined interconnectivities, and some have utilized os-
teoinduction by BMPs to study bone ingrowth,35,47,55 which
could interfere or even disturb osteoconduction. In the vast
majority of reports on osteogenesis and pore size, the pores
were <0.5mm in diameter, and thus did not include a wide-
open microarchitecture. There is only one in vivo study with
different scaffolds containing pores from 0.5 up to 1.2mm,
showing that bone ingrowth was independent of pore di-
ameter in this range.64 The limitations of this study were
that scaffolds with pores >1.2mm were not tested, the dis-
tribution of the pores in the scaffolds was random, and their
interconnection undefined.
Therefore, all the examples given in this chapter provide
some insight into osteoconductive, pore-based micro-
architectures. However, overall, these results were based on
many different materials and diverse in vivo systems, and
thus, even if taken together, they fail to produce a com-
prehensive overview of osteoconduction as a phenomenon.
One reason for this puzzling picture of osteoconduction in
the literature is certainly limitations in the production meth-
odologies to produce a library of defined microarchitectures to
test for osteoconduction in a more systematic manner. In one
study, the mold to generate tubular microarchitectures with
pores of 0.5mmwas produced by additive manufacturing. In a
tibial defect model, this scaffold performed significantly better
than the traditional random porous microarchitectures.65
Therefore, additive manufacturing appears to be the tool of
choice to produce libraries of scaffolds with diverse mi-
croarchitectures and to systematically study the effect of
microarchitecture on osteoconduction.
Osteoconduction and Microarchitectures Derived
from Additive Manufacturing
The effectiveness of 3D printing as an additive manu-
facturing technique in regenerativemedicine, particularly bone
tissue engineering, has been extensively reviewed,66–68 as have
the diverse additive manufacturing methodologies.69 How-
ever, studies of the relationship between microarchitecture
and osteoconduction are rather limited in number.70,71 Ad-
ditive manufacturing, in contrast to subtractive methodolo-
gies, creates an object layer by layer. Examples of additive
manufacturing methodologies are stereolithography, selective
laser sintering,72 and 3D printing in a powder bed.73 The latter
has been applied for ceramics to build bone substitutes.74,75
Melt-extrusion additive manufacturing was established in
199276 and solution/slurry/gel extrusion in 2002.77,78 In
all extrusion-based methodologies, a polymeric filament is
extruded through a nozzle and deposited layer by layer on
a building platform. This also applies to fused deposition
OSTEOCONDUCTION 379
modeling with poly-e-caprolactone.79,80 All filament-based
additive manufacturing methodologies have the disadvantage
that the resulting microarchitecture is highly dependent on the
dimension and the mechanical constraints predefined by the
filament at the time point of extrusion. In the majority of ex-
amples, the pore size in the x, y-axis equals the distance be-
tween the filaments. Here, the distance has to be in line with
themechanics of the filament just after extrusion to prevent the
filament from bending or even collapsing onto a lower
building level (Fig. 3b, c). In the z-axis, the pore diameter is
predefined by the thickness of the filaments, and if not, mul-
tiple layers of filaments are deposited on top of each other.
Overall, filament-based additive manufacturing very much
constrains the variability of the microarchitecture, and appears
less suited to study the relationship between osteoconduction
and microarchitecture in detail. This does not imply that a
filament-based 3D printing approach could not be used to
produce the best osteoconductive microarchitecture in the
future. However, in the search for an ideal osteoconductive
microarchitecture, lithography-based additive manufacturing
methodologies might be the best suited to study micro-
architecture and osteoconduction due to their high resolution
(the layer thickness can be set as low as 0.04mm and the x-y-
resolution even smaller81) and the greater design freedom.
Early studies on polylactide-based scaffolds produced
by 3D techniques showed worse bony bridging than seen
with negative controls; that is, the empty defect.82 When
the same design was realized with hydroxyapatite-based
scaffolds, osteoconduction with the scaffolds slightly ex-
ceeded bony bridging in the empty defects.83 However, the
radial pores in this design had a dimension of 1.6 · 1.0mm,
which might have been too large for osteoconduction to
occur efficiently.84 Overall, this result suggests that the
choice of material and its associated possible degradation
products can influence or even overwrite osteoconduction.
Therefore, microarchitectures should be studied with slow
degrading or nondegrading materials, such as calcium phos-
phates or titanium.
Titanium has been used extensively as a bone substitute
due to its biocompatibility and mechanical strength, al-
though it lacks biodegradability. In vivo tests with scaffolds
containing pores between 0.30 and 0.90mm illustrated that
the scaffold with the smallest pore size showed reduced
bone ingrowth.85 In another study, a scaffold with 0.6mm
pores performed slightly better than ones with 0.9mm
pores.86 These results have also been observed by others,87
looking at a similar array of pore dimensions.
In a more recent report, porous titanium implants pro-
duced by selective laser melting were tested in a sheep long
bone in vivo model. The diamond-shaped unit cells had
dimensions of 0.6, 0.9, and 1.2mm. Unfortunately; the strut
size between the unit cells differed between the structures
and reduced the open pores to <0.4mm. Here, a unit cell of
0.9mm showed the best bone ingrowth.88 Pores 3.2mm in
diameter were used for honeycomb-shaped meshes to
generate mechanobiologically optimized configurations
for scaffolds to successfully treat large bone defects.89,90
Such mesh-type scaffolds have not been tested or optimized
for osteoconduction, but only examined in view of their me-
chanics and stress shielding capabilities.
Numerous additively manufactured scaffolds have been
produced from doped and nondoped bioglass. With a pore
size of 0.25mm, no significant difference was seen between
filament-based lattice structures, oriented pore structures,
and autologous bone in critical-size segmental defects in rat
femora.91 Similar results were achieved in an in vivo rabbit
FIG. 3. Freely formed and
filament-based implants and
their designs. (a) A freely
designed pore-based implant
is shown. The drawing below
represents a three-dimensional
view of the design and in the
lowest panel the view from
the front. Respective views of
filament-based designs are
displayed from (b) a thin and
(c) a twice as thick filament.
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model with a filament-based lattice structure forming pores
of 0.15 · 0.20mm.92 These results show that such scaffolds
can substitute for the use of autologous bone in critical-size
defects. However, to date, wide-open microarchitectures
with pores between 0.7 and 1.2mm have not been tested.
In terms of bone ingrowth and osteoconduction in additive
manufactured scaffolds, the majority of results are derived
from scaffolds produced using filament-based methodologies
(Fig. 3), since these machines are simpler and cheaper than
most other systems. In a recent study, foamed and filament-
based 3D-printed scaffolds from the same material were
compared in femur defects in Beagle dogs. For both TCP-
based scaffolds, the pore size varied in diameter between
0.227mm for the foamed and 0.288 and 0.409mm for the
printer scaffolds. In terms of bone formation, the foamed
scaffold performed significantly better.93 In another study,
filament-based scaffolds with channels of 0.10, 0.25, and
0.40mm were tested in calvarial defects in mice. Here, scaf-
folds with 0.10mm channels performed better than more open
channels.94 Because the defect only had a depth of 0.5mm, the
animal study design might have favored the smaller channels.
A more demanding radial diaphysis model in New
Zealand white rabbits was applied with the result that the
3D-printed segmental bone substitute was superior to the
solid block.95 The first study comparing different micro-
architectures with a filament-based extrusion system was
undertaken with polycaprolactone (PCL)/TCP filaments
with pores between 0.42 and 0.50mm. Due to the filament
thickness, the pore height was limited to 0.3mm. Both mi-
croarchitectures varied in the orientation of the laydown
patterns of the filaments, and in vivo, the scaffold with a 0/
90 orientation performed better in terms of bone formation
than the counterpart in which the filaments of the layers
followed a 0/60/120.96 That the laydown pattern affects
the mechanical strength of a scaffold was shown earlier.97
Its influence on the osteoconduction of these two scaffolds
FIG. 4. Design and in vivo testing of TCP-based scaffolds. (a) Unit cell with increasing bottleneck. (b) Construction of
scaffold for in vivo testing from unit cell to scaffolds displayed on a five Swiss Franc coin. (c) Pore distribution and
bottleneck dimension (B) are shown. Scaffold is shown in dark blue, and pores are shown in gray. (d) Percentage of bony
bridging of the defect in relation to pore and bottleneck dimensions. Compared with the empty control, scaffolds with pore
diameters from 0.7 to 1.7mm and bottlenecks <1.5mm perform significantly better. Scaffolds with pores of 1.2mm and
bottlenecks between 0.7 and 1.2 perform significantly better than scaffolds with a pore diameter of 1.5 and bottleneck of 1.2
and with a pore diameter of 1.7 and bottleneck of 0.7. The results from each group are displayed as the mean – standard error
of the mean. Data are drawn from Ghayor and Weber84 with permission.
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supports the notion that there is a tight relationship between
microarchitecture and osteoconduction.
All the aforementioned studies, even when additive
manufacturing was applied for production of the scaffolds,
predominantly compared 1–3 scaffolds with ‘‘textbook’’ pore
dimensions between 0.3 and 0.5mm, which favors bone
growth on the surface.35 However, the search for highly os-
teoconductive microarchitectures should also include wide-
open porous architectures. Such orthogonal periodic porous
microarchitectures with pores of 1.75–2.5mm were produced
from PCL through additive manufacturing.98 However, in the
associated in vivo test, BMPs were applied, and the scaffolds
were implanted subcutaneously. Therefore, these scaffolds
were not tested for osteoconduction but for osteoinduction.
In 2018, the first library of narrow and wide-open lattice
microarchitectures constructed from titanium was tested for
osteoconduction in a calvarial defect model in rabbits. The
outcome of this study revealed that the most osteoconductive
lattice architecture is one consisting of rods with a thickness
of 0.3mm at a distance of 0.8mm from each other.36 To test
the material dependence of this finding, microarchitecturally
identical titanium and TCP scaffolds were compared, and no
difference in the ingrowth of bone was found.99 This is rea-
sonable because with pores wider than 0.5mm bone grows
between the rods (Fig. 2), and therefore, bone growth may not
be as dependent on the scaffold material,35 as long as it
maintains its osteoconductive guiding capability. However,
the essence of this guiding capability is still elusive.
The most osteoconductive microarchitecture based on
round pores connected by tubes (Fig. 4c) was identified with a
library of 15 different scaffolds produced from TCP84 (Fig. 4).
Here, we found the best pore diameter to be 1.2mm, per-
forming significantly better than pores of ‡1.5mm.84 With
highly osteoconductive wide-open porous microarchitectures
with pores 1.2mm in diameter, bony bridging reached
90.4– 4.5% (mean– standard error of the mean [SEM]), a
much higher value than that obtained with the 0.5mm pores
(consistent with the old dogma of the ideal pore diameter),
yielding bony bridging of just 54.4– 15.2% (mean–SEM).
Therefore, wide-open porous microarchitectures with pores
and bottlenecks between 0.7 and 1.2mm in diameter appear
to be highly osteoconductive.
The results from the osteoconductive lattice structure study
determined in titanium-based scaffolds with an optimal rod
distance of 0.8mm are almost superimposable with the ideal
pore diameter of 1.2mm found with TCP-based scaffolds,
since the diagonal of such a square would measure 1.13mm
(Fig. 5). Therefore, these newly defined boundaries of 1.13–
1.20mm maximal distance between material surfaces for
highly osteoconductive wide-open microarchitectures might
be applicable to diverse materials and diverse microarchi-
tectures. However, further studies are necessary to confirm or
reject this hypothesis.
Concluding Remarks
Since the 1990s, the excitement in the field of bone tissue
engineering directed toward osteoinduction and the use of
stem cells has hampered interest in applying and developing
osteoconduction as another major driving force in bone re-
generation. For spurious reasons and without systematic
studies, mainly due to the lack of production methodologies,
the field agreed on the optimal microarchitecture in terms of
pore diameters for bone substitutes to be between 0.3 and
0.5mm. In the meantime, new methodologies to freely design
and realize microarchitectures in bone substitutes were de-
veloped, namely additive manufacturing. This new technol-
ogy is a game changer not only in manufacturing of goods but
also in our ability to freely design and produce new osteo-
conductive microarchitectures and test them in vivo.
Recent studies of porous structures increased the optimal
pore size to 1.2mm and the optimal osteoconductive lattice
structure to rods of *0.3mm in diameter and a spacing
between rods of 0.8mm. Both results translate to micro-
architectures with a maximal optimal surface distance of
1.13–1.20mm. Additive manufacturing will also be instru-
mental in studying the essence of osteoconduction. Already,
wide-open porous microarchitectures could be realized
through additive manufacturing, and osteoconductive bone
ingrowth in those structures was shown to occur predomi-
nantly in the space between the material and not on the
surface of the material forming the scaffold (Fig. 2).
Therefore, these results support the early definition of os-
teoconduction as a 3D process of ingrowth of sprouting
capillaries, perivascular tissue, and osteoprogenitor cells
from a bony bed into the 3D structure of a porous implant
(adjusted from Cornell and Lane9; Urist10) used as a guiding
cue to bridge a defect with bony tissue. With this new tool of
FIG. 5. Schematic drawing
of osteoconductive micro-
architectures. (a) In titanium-
based lattice scaffolds, the
optimal osteoconductive rod
distance measures 0.8mm.
(b) For TCP-based porous
scaffolds, the optimal osteo-
conductive pore diameter is
1.2mm. (c) Because the rods
form squares, the diagonal of
the most osteoconductive
squares and the most osteo-
conductive pore diameter are
almost identical (1.13 and
1.20mm, respectively).36,84
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additive manufacturing in hand, further studies on the es-
sence of osteoconduction in terms of microarchitecture and
guiding cues can be undertaken in the future.
In a recent commentary, it was postulated that ‘‘the ideal
scaffold architecture does not exist, since each scaffold must
fulfill several functions, such as resorption, bone ingrowth and
mechanical support.’’100 Here, in this review, we only looked
at microarchitecture and osteoconduction, and defined certain
microarchitectures to be highly osteoconductive in terms of
bony defect bridging.36,84 Since bony defect bridging is the
key element in avoiding nonunions, and given the clinical and
economic burden of treating nonunions,101 there is an obvious
need to develop bone substitutes with high osteoconductive
properties in terms of osteoconductive microarchitectures.
Based on this key input showing that osteoconductive
microarchitectures avoid nonunions, materials must be de-
veloped for generation of new scaffold designs with the
hope of meeting the mechanical and degradation needs and
combining all these elements into one implant. Indisputably
and in agreement with the comment,100 this is a very tricky
if not impossible task. However, dismissing the profound
impact of scaffold microarchitecture on osteoconduction
and the associated acceleration of bony bridging during
bone regeneration would leave us with suboptimal bone
substitutes. The alternative and more easily achievable ap-
proach would be to meet the mechanical needs indepen-
dently of the bone substitute through conventional or even
biodegradable osteosynthesis materials, such as plate and
screw systems, and the bone substitute itself can be built by
applying an optimally osteoconductive microarchitecture
with well-known and well-established scaffold materials.
In essence, in the last 25 years, the field of bone tissue
engineering followed the old rules for optimal micro-
architectures of bone substitutes, forgot about the potential of
osteoconduction, and focused predominantly on new, exciting
developments, such as osteoinduction and the use of stem
cells in bone repair. Now, with new technologies, such as
additive manufacturing, in hand, we are able to design and
realize an unlimited number of microarchitectures. This en-
ables us to test these microarchitectures for osteoconduction
and to define new boundaries for osteoconductive micro-
architectures of bone substitutes, and thus further advance the
field of bone tissue engineering through microarchitecturally
designed, highly osteoconductive scaffolds alone or in com-
bination with osteoinductive factors and/or stem cells.
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